Relevant bibliographies by topics / Cyclophosphamide

Academic literature on the topic 'Cyclophosphamide'

Author: Grafiati
Published: 4 June 2021
Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cyclophosphamide.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cyclophosphamide"

1

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 369 (September 1991): 7. http://dx.doi.org/10.2165/00128415-199103690-00025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 375 (November 1991): 6. http://dx.doi.org/10.2165/00128415-199103750-00027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Cyclophosphamide see Carboplatin/cyclophosphamide." Reactions Weekly &NA;, no. 380 (December 1991): 4. http://dx.doi.org/10.2165/00128415-199103800-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Cyclophosphamide see Indomethacin/cyclophosphamide." Reactions Weekly &NA;, no. 283 (January 1990): 4. http://dx.doi.org/10.2165/00128415-199002830-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 324 (October 1990): 4. http://dx.doi.org/10.2165/00128415-199003240-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Cyclophosphamide see Prednisone/cyclophosphamide." Reactions Weekly &NA;, no. 343 (March 1991): 4. http://dx.doi.org/10.2165/00128415-199103430-00018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 358 (July 1991): 7. http://dx.doi.org/10.2165/00128415-199103580-00028.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

&NA;. "Cyclophosphamide see Chlorambucil/cyclophosphamide/methotrexate." Reactions Weekly &NA;, no. 348 (April 1991): 7. http://dx.doi.org/10.2165/00128415-199103480-00024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

&NA;. "Cyclophosphamide." Reactions Weekly &NA;, no. 1380 (December 2011): 15. http://dx.doi.org/10.2165/00128415-201113800-00053.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

&NA;. "Cyclophosphamide." Reactions Weekly &NA;, no. 1384 (January 2012): 21. http://dx.doi.org/10.2165/00128415-201213840-00081.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cyclophosphamide"

1

Levy, Karine. "Toxicité du cyclophosphamide." Paris 5, 1993. http://www.theses.fr/1993PA05P156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Afsharian, Parvaneh. "Optimization of cyclophosphamide therapy based on pharmacogenetics /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-997-1/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yule, S. M. "The clinical pharmacology of cyclophosphamide in children." Thesis, University of Newcastle Upon Tyne, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309831.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chanellière, Christiane. "Intérêt de l'utilisation du cyclophosphamide dans le traitement des pemphigoi͏̈des bulleuses et des pemphigus." Montpellier 1, 1989. http://www.theses.fr/1989MON11064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Belfayol-Pisanté, Laurence. "Evaluation d'un index prédictif de l'apparition des effets secondaires liés au traitement par le cyclophosphamide chez des patients atteints de vascularites et de collagénoses." Paris 5, 2000. http://www.theses.fr/2000PA05P629.

Full text
Abstract:
Le cyclophosphamide est un agent anticancéreux et immunosuppresseur utilisé aussi bien dans le traitement des affections malignes que des maladies systémiques. Si les études pharmacocinétiques ont été largement décrites chez les patients traités par le cyclophosphamide seul ou en association pour ses propriétés antinéoplasiques, aucune n'aborde la pharmacocinétique du cyclophosphamide et de son métabolite, le 4-hydroxycyclophosphamide/aldophosphamide, chez les patients atteints de vascularites ou de collagénoses. En raison de la toxicité liée au traitement par le cyclophosphamide chez ces sujets à risque, notamment en termes d'infections, nous avons étudié s'il existait une relation entre les paramètres pharmacocinétiques et la survenue des effets indésirables. Les résultats ont montré que les paramètres pharmacocinétiques du cyclophosphamide et de son métabolite sont comparables à ceux retrouvés chez le patient cancéreux. Cependant la variabilité inter-individuelle est plus importante dans notre étude [. . . ]
Cyclophosphamide is an alkylating agent widely used for the treatment of malignant dis eases. It also has been used to treat systemic vasculitides. This immunosuppressive therapy, given in association with corticosteroids, has markedly improved the prognosis of these diseases. Although the pharmacokinetics of cyclophosphamide in cancer patients have been well documented, no information has been reported on cyclophosphamide pharmacokinetics in patients with systemic vasculitis and connectivitis. The aim of this study was to evaluate the concentrations and pharmacokinetic parameters of cyclophosphamide and its key circulating intermediate metabolite, 4-hydroxycyclophosphamide/aldophosphamide, in these patients and to define a relationships between pharmacokinetic parameters and toxic effects. The results are consistent with those obtained for cancer patients, in spite of a wide inter-patient variability of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide concentrations in our study [. . . )
APA, Harvard, Vancouver, ISO, and other styles
6

Lo, Kwun-hang Kenny. "Effects of cyclophosphamide on ulcer in rat stomachs /." View the Table of Contents & Abstract, 2004. http://sunzi.lib.hku.hk/hkuto/record/B30708825.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

盧冠恆 and Kwun-hang Kenny Lo. "Effects of cyclophosphamide on ulcer in rat stomachs." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B45010158.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Maynard-Faure, Patricia. "Synthèse d'analogues bicycliques préactives du cyclophosphamide et de l'aldophosphamide." Lyon 1, 1997. http://www.theses.fr/1997LYO10268.

Full text
Abstract:
Ce memoire de these concerne l'etude de voies de synthese de nouveaux analogues du cyclophosphamide et de l'aldophosphamide. Apres avoir rappele la place du cyclophosphamide, agent cancerostatique le plus utilise en clinique humaine, dans l'arsenal des medicaments anticancereux, nous avons passe en revue les nombreux analogues deja synthetises en vue d'obtenir des composes a index therapeutique plus eleve. Nous presentons ensuite des voies de syntheses possibles pour des derives bicycliques preactives cibles ne necessitant pas d'activation biologique. Ce travail a permis de completer l'etude des voies d'acces au 3-n,n-bis (2-chloroethyl) amino -3-oxo-2-aza-4,9-dioxa-3-phosphabicyclo- (4, 3, 0) nonane precedemment synthetise, mais aussi de preparer de nouveaux analogues spiranniques en serie furanique et pyranique. Il a ete largement etendu en serie sucre par la preparation de composes du meme type derives du d-arabinose et du d-glucose. Ces preparations ont ete l'occasion de mettre au point de nouvelles methodologies, concernant notamment la synthese apres allongement de chaine d'azidoalcools originaux derives de l'arabinose et la n-glycosylation intramoleculaire de phosphoramides. La determination de la structure des nouveaux composes a necessite une analyse approfondie au moyen des techniques de resonance magnetique nucleaire les plus recentes, apportant par la-meme de nouvelles informations sur les facteurs influencant la geometrie des heterocycles du type oxazaphosphorinane. L'existence de conformations non chaises semble etre ainsi la regle pour des structures steriquement contraintes.
APA, Harvard, Vancouver, ISO, and other styles
9

Lu, Hong. "Pharmacokinetic and drug metabolism studies of cyclophosphamide and ifosfamide /." The Ohio State University, 1998. http://rave.ohiolink.edu/etdc/view?acc_num=osu148795015360318.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Li, Zhaoyang. "DNA alkylation by active metabolites of Cyclophosphamide and Ifosfamide /." The Ohio State University, 1999. http://rave.ohiolink.edu/etdc/view?acc_num=osu1488192960169091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Cyclophosphamide"

1

Boche, Gernot. Cyclopropane derived reactive intermediates. Chichester: Wiley, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Asli-Yalfani, Esmael. Cellular and molecular studies of the immunopharmacology of cyclophosphamide. Manchester: University of Manchester, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Azria, M. (Moïse). Calcitonins: Physiological and pharmacological aspects. Berlin: Springer Verlag, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lewtas, Joellen. Final report on the evaluation of four toxic chemicals in an In Vivo/In Vitro toxicological screen--acrylamide, chlordecone, cyclophosphamide, and diethylstilbestrol. Research Triangle Park, N.C: U.S. Environmental Protection Agency, Health Effects Research Laboratory, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Blokdijk, G. J. Cyclophosphamide; The Ultimate Step-By-Step Guide. CreateSpace Independent Publishing Platform, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

R, Nowrousian M., ed. Ifosfamide in cancer therapy: A comparison with cyclophosphamide. Jena: Universitätsverlag, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cyclophosphamide: Clinical Pharmacology, Uses and Potential Adverse Effects. Nova Science Publishers, Incorporated, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Publications, ICON Health. Cyclophosphamide - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chen, Chu-liang. Identification of an inguinal adipocyte-specific protein using monoclonal antibody selected by cyclophosphamide. 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Progress in Clinical Biochemistry and Medicine. Springer Verlag, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Cyclophosphamide"

1

Maxwell, Robert A., and Shohreh B. Eckhardt. "Cyclophosphamide." In Drug Discovery, 265–80. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0469-5_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, and Sabine Wassertheurer. "Cyclophosphamide." In Extravasation of Cytotoxic Agents, 155–59. Vienna: Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Schwab, Manfred. "Cyclophosphamide." In Encyclopedia of Cancer, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_1439-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bartlett, R. R. "Cyclophosphamide." In Handbook of Experimental Pharmacology, 453–69. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73217-1_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Scorer, Matthew, Olga Golberg, and Karen Harman. "Cyclophosphamide." In Handbook of Systemic Drug Treatment in Dermatology, 112–19. 3rd ed. London: CRC Press, 2022. http://dx.doi.org/10.1201/9781003016786-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Curtis, John J. "Cyclophosphamide." In Immunotherapy in Transplantation, 290–95. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781444355628.ch19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Cyclophosphamide." In Extravasation of Cytotoxic Agents, 92–94. Vienna: Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

de Groot, Anton C. "Cyclophosphamide." In Monographs In Contact Allergy, 342. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003158004-160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Neumann, Ron. "Cyclophosphamide." In Intraocular Inflammation, 323–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-540-75387-2_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Saxena, Ajit Kumar, and Amit Kumar. "Introduction of Cyclophosphamide." In Fish Analysis for Drug and Chemicals Mediated Cellular Toxicity, 1–5. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4700-3_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cyclophosphamide"

1

Kobrová, Kateřina, Lenka Minxová, Jakub Zieg, Sylva Skálová, and Pavla Doležalová. "AB0998 SEVERE IGA VASCULITIS: CYCLOPHOSPHAMIDE IN QUESTION." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6731.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ertenli, Ý., V. Cobankara, S. Apras, S. Kiraz, MA Oztürk, and M. Çalgüneri. "AB0079 Cyclophosphamide exposure during pregnancy: two cases." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

VIEIRA, ADAH SOPHIA RODRIGUES, GUILHERME LOPES PEREIRA, ANTÔNIO JOSÉ DA SILVA NETO, ALINE DE CASTRO CARACAS, RODRIGO BARBOSA DE AZEVEDO, and REJANE MARIA RODRIGUES DE ABREU VIEIRA. "RITUXIMAB IN POLYARTERITIS CYCLOPHOSPHAMIDE INTOLERANT NODOSE: CASE REPORT." In 36º Congresso Brasileiro de Reumatologia. São Paulo: Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tanaka, N., A. Hirano, H. Inoue, K. Ogura, A. Hattori, N. Jibiki, H. Yukawa, et al. "Abstract OT1-01-02: A phase II trial of neoadjuvant docetaxel/cyclophosphamide followed by epirubicin/cyclophosphamide for triple-negative breast cancer." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-ot1-01-02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Constantin, Mirela Alina, Lucian Alexandru Constantin, Nicolae Ionut Cristea, and Ines Nitoi. "INFLUENCE OF TiO2 DOPANT TYPE UPON CYCLOPHOSPHAMIDE DEGRADATION EFFICIENCY." In International Symposium "The Environment and the Industry". National Research and Development Institute for Industrial Ecology, 2017. http://dx.doi.org/10.21698/simi.2017.0003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Son, R., D. Hwang, AH Jung, JM Lim, SH Jung, SY Suh, HJ Hahn, YS Cho, EJ Park, and HI Cheong. "5PSQ-082 Cyclophosphamide therapy in children with nephrotic syndrome." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.436.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chalwadi, U. K., M. Pertzborn, N. Swamy, and A. Agarwal. "Cyclophosphamide-Induced Late Onset Pulmonary Fibrosis in Pediatric Patient." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kong, Chia Wei, Oluwatobi Adeagbo, Robert Hooper, Vanessa Titmuss, and Suresh Babu. "Usefulness of pulsed cyclophosphamide in Interstitial Lung Disease (ILD)." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa2982.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yamauchi, Kensuke, Meng Yang, Katsuhiro Hayashi, Ping Jiang, Mingxu Xu, Norio Yamamoto, Hiroyuki Tsuchiya, et al. "Imaging enhancement of malignancy by cyclophosphamide: surprising chemotherapy opposite effects." In Biomedical Optics (BiOS) 2008, edited by Alexander P. Savitsky, Robert E. Campbell, and Robert M. Hoffman. SPIE, 2008. http://dx.doi.org/10.1117/12.772085.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Daillere, Romain, Marie Vetizou, and Laurence Zitvogel. "Abstract 4928: Impact ofE. hiraeon the tumoricidal activity of cyclophosphamide." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-4928.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cyclophosphamide"

1

Lao, Lixing, and Richard H. Wong. The Effect of Electroacupuncture on Cyclophosphamide-Induced Emesis in Ferrets. Fort Belvoir, VA: Defense Technical Information Center, July 1995. http://dx.doi.org/10.21236/ada299200.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Yin, Xietian, Shichao Zhao, Nan Xiang, Jidong Chen, Jun Xu, and Yudan Zhang. Efficacy and Safety of Chinese Herbal Medicines combined with Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease: A Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0010.

Full text
Abstract:
Review question / Objective: To evaluate the effectiveness and safety of Chinese herbal medicines (CHMs) combined with cyclophosphamide (CTX) for connective tissue disease-associated interstitial lung disease (CTD-ILD) by performing a meta-analysis. Condition being studied: Chinese herbal medicines (CHMs) and cyclophosphamide (CTX) are widely used in the treatment of connective tissue disease-associated interstitial lung disease (CTD-ILD). However, the clinical benefits of CHMs treatment for CTD-ILD are still controversial, and there is no systemic review to summarize and evaluate their efficacy and safety.
APA, Harvard, Vancouver, ISO, and other styles
3

Zhang, LiBo, GuangZhen Liu, and YanChuang Liang. Meta analysis of traditional Chinese medicine combined with cyclophosphamide in the treatment of adult refractory nephrotic syndrome. International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2020. http://dx.doi.org/10.37766/inplasy2020.5.0020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Emens, Leisha A., and Elizabeth M. Jaffee. Enhancement of an Allogeneic GM-CSF-Secreting Breast Cancer Vaccine by Immunomodulatory Doses of Cyclophosphamide and Doxorubicin. Fort Belvoir, VA: Defense Technical Information Center, June 2003. http://dx.doi.org/10.21236/ada417167.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cyclophosphamide' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography